What does Integ. Proteins do?

Integrated Proteins Ltd processes oil seeds in the Edible Oil industry and has a market cap of Rs 16 Cr. As of March 2025, it reported net sales of 21 Cr and a net profit of 0 Cr, with a P/E ratio of 16.00.

Overview: <BR>Integrated Proteins Ltd is engaged in the processing of various oil seeds and operates within the Edible Oil industry, categorized as a Micro Cap company.<BR><BR>History: <BR>Integrated Proteins Limited was incorporated as a public limited company in October 1992. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Net Sales: 21 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market cap: Rs 16 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Industry P/E: 24 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.01 <BR>Return on Equity: 9.58% <BR>Price to Book: 6.24<BR><BR>Contact Details: <BR>Address: City Point Opp Town Hall, Station Road Jamnagar Gujarat : 361008 <BR>Tel: 91-288-2551901/902/903 <BR>Email: ps@arcadia.co.in <BR>Website: http://www.integratedproteins.com

Has Integ. Proteins declared dividend?

No Dividend History Available

Who are the peers of the Integ. Proteins?

Peers of Integ. Proteins include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, and others. Marico shows excellent management and capital structure, while Integ. Proteins has average growth and a 1-year return of 129.69%.

Peers: The peers of Integ. Proteins are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, CIAN Agro, Natraj Proteins, Ashiana Agro Ind, and Signature Green.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods and Gokul Agro, and the rest have Below Average management risk. Growth is Excellent at Patanjali Foods and Gokul Agro, Good at AWL Agri Busine. and CIAN Agro, while Average growth is seen at Integ. Proteins, and the rest have Below Average growth. Excellent capital structure is noted at Marico and Sundrop Brands, Good at Patanjali Foods, AWL Agri Busine., and Gokul Agro, while Integ. Proteins and the rest have Below Average or do not qualify.<BR><BR>Return Snapshot: CIAN Agro has the highest 1-year return at 1037.81%, while AWL Agri Busine. has the lowest at -27.15%. Integ. Proteins has a 1-year return of 129.69%, which is significantly higher than AWL Agri Busine. Additionally, the six-month return is negative for AWL Agri Busine., Gokul Agro, Ashiana Agro Ind, and Integ. Proteins.

What is the technical trend for Integ. Proteins?

As of June 4, 2025, Integ. Proteins shows a mildly bearish trend, with bearish weekly MACD and moving averages, despite mixed signals from the monthly indicators.

As of 4 June 2025, the technical trend for Integ. Proteins has changed from does not qualify to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish, indicating a weakening momentum. The daily moving averages are also bearish, reinforcing the negative sentiment. The Bollinger Bands show a mildly bearish stance on the weekly chart, contrasting with a bullish outlook on the monthly chart. The KST is bearish on the weekly timeframe but bullish monthly, suggesting mixed signals. Overall, the current technical stance is mildly bearish, driven primarily by the bearish indicators on the MACD and moving averages.

Who are in the management team of Integ. Proteins?

As of March 2023, the management team of Integ. Proteins includes Vinod P Mehta (Chairman), Arvindbhai Kantilal Shah (Managing Director), Piyush Chimanalal Vora (CFO), and several independent and non-executive directors. They oversee the company's strategic direction and operations.

As of March 2023, the management team of Integ. Proteins includes the following individuals:<BR><BR>1. Vinod P Mehta - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. Arvindbhai Kantilal Shah - Executive Director & Managing Director<BR>3. Piyush Chimanalal Vora - Executive Director & Chief Financial Officer<BR>4. Bhalchandra Vyas - Independent Non-Executive Director<BR>5. Vijaykumar Shamjibhai Dattani - Independent Non-Executive Director<BR>6. Neepa Praful Kothari - Non-Executive & Non-Independent Director<BR><BR>This team is responsible for overseeing the company's strategic direction and operations.

Who are the top shareholders of the Integ. Proteins?

The top shareholders of Integ. Proteins include Siddheshwar Advisory Private Limited with 23.89%, and promoter Vinod Prabhulal Mehta with 10.06%. Individual investors collectively hold 47.19%, with no institutional holdings or pledged shares reported.

The top shareholders of Integ. Proteins include Siddheshwar Advisory Private Limited, which holds the largest public share at 23.89%. The promoter with the highest individual holding is Vinod Prabhulal Mehta, who owns 10.06%. Additionally, individual investors collectively hold 47.19% of the company. There are no institutional holdings or pledged promoter shares reported.

How big is Integ. Proteins?

As of 21st July, Integrated Proteins Ltd has a market capitalization of 17.00 Cr, with net sales of 21.50 Cr and a net profit of 0.25 Cr in the latest four quarters. Specific values for Shareholder's Funds and Total Assets are unavailable.

As of 21st July, Integrated Proteins Ltd has a market capitalization of 17.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported net sales of 21.50 Cr and a net profit of 0.25 Cr.<BR><BR>The reporting period for the balance sheet data is the latest annual period, but specific values for Shareholder's Funds and Total Assets are unavailable.

When is the next results date for Integ. Proteins?

Integ. Proteins is scheduled to announce its results on 14 August 2025.

Integ. Proteins is scheduled to declare its results on 14 August 2025.

Are Integ. Proteins latest results good or bad?

Integrated Proteins' latest results show a mixed performance with improved net sales and profit, but concerns remain due to thin operating margins, erratic revenue patterns, and negative return on capital employed. While there are signs of recovery, the overall instability suggests caution for potential investors.

The latest results for Integrated Proteins indicate a mixed performance. In Q2 FY26, the company reported net sales of ₹4.20 crores, a significant improvement from ₹0.00 crores in the previous quarter (Q1 FY26). Additionally, it achieved a net profit of ₹0.05 crores, compared to no profit in Q1 FY26. This marks a positive shift, as the company is emerging from a period of operational dormancy.<BR><BR>However, despite these improvements, the overall financial health of Integrated Proteins raises concerns. The operating margin remains very thin at just 2.14%, and the company has shown erratic revenue patterns, with a notable drop from ₹21.49 crores in Q4 FY25 to the current quarter's figures. This volatility suggests that the recent uptick in sales may not be sustainable.<BR><BR>Moreover, the company's return on equity (ROE) of 8.75% is better than its historical average, but the average return on capital employed (ROCE) remains negative, indicating ongoing challenges in generating value. The lack of institutional interest and the micro-cap status further complicate the outlook.<BR><BR>In summary, while there are signs of recovery with positive sales and profit figures, the overall performance is still characterized by instability and uncertainty, making it difficult to label the results as definitively good or bad. Caution is advised for potential investors.

Should I buy, sell or hold Integ. Proteins?

How has been the historical performance of Integ. Proteins?

Integ. Proteins has shown significant growth, with net sales reaching 21.50 Cr in March 2025, up from 0.24 Cr in March 2024. The company also reported increased operating profit, profit before tax, and profit after tax, alongside a rise in earnings per share to 0.71.

Answer:<BR>The historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability.<BR><BR>Breakdown:<BR>Integ. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the company achieved net sales of 21.50 Cr in March 2025, marking a significant increase from 0.24 Cr in March 2024. This growth is mirrored in the total operating income, which also reached 21.50 Cr in March 2025. The operating profit has turned positive, with a reported 0.34 Cr in March 2025, compared to a loss of 0.11 Cr in March 2024. Profit before tax and profit after tax have both shown substantial increases, reaching 0.32 Cr and 0.25 Cr respectively in March 2025, indicating improved profitability. The earnings per share have also risen to 0.71, reflecting the company's enhanced financial health. Overall, Integ. Proteins has transitioned from a period of minimal activity to a phase of significant growth and profitability.

Is Integ. Proteins overvalued or undervalued?

As of November 27, 2025, Integ. Proteins is considered undervalued with an attractive investment appeal, reflected in its favorable PE ratio of 42.60 and EV to EBITDA of 14.06, despite a year-to-date return of -49.13%, while showing a strong three-year return of 97.78%.

As of 27 November 2025, the valuation grade for Integ. Proteins has moved from risky to attractive, indicating a significant improvement in its investment appeal. The company is currently considered undervalued. Key ratios include a PE ratio of 42.60, an EV to EBITDA of 14.06, and a PEG ratio of 0.11, which suggests that the stock is priced favorably relative to its growth potential.<BR><BR>In comparison to its peers, Integ. Proteins has a higher PE ratio than CIAN Agro, which stands at 33.9, but lower than Manorama Industries at 43.54. The EV to EBITDA ratio of Integ. Proteins is also more favorable than that of Manorama Industries, which is 28.15. Despite the recent underperformance in the stock's year-to-date return of -49.13% compared to the Sensex's 9.70%, the long-term performance over three years shows a remarkable return of 97.78%, reinforcing the potential for recovery and growth in value.

Which are the latest news on Integ. Proteins?

Which are the latest news on Integ. Proteins?

Why is Integ. Proteins falling/rising?

As of 22-Dec, Integrated Proteins Ltd's stock price is rising to Rs 38.00, reflecting a 4.83% increase due to strong recent performance, increased investor participation, and a significant outperformance compared to its sector. Despite a long-term decline, the recent momentum indicates a positive shift in investor sentiment.

As of 22-Dec, Integrated Proteins Ltd's stock price is rising, currently at Rs 38.00, which reflects an increase of Rs 1.75 or 4.83%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 8.61% today and has shown a consecutive gain over the last three days, accumulating a total return of 15.5% during this period. Additionally, there has been a significant increase in investor participation, with delivery volume on 19 December rising by an impressive 2197.93% compared to the five-day average. <BR><BR>Moreover, the stock's performance over the past week has been strong, with a 10.79% increase, contrasting sharply with the Sensex's modest gain of only 0.42%. Although the stock has experienced declines over the longer term, such as a year-to-date drop of 49.46%, the recent positive momentum and increased trading activity suggest a shift in investor sentiment. The stock also reached an intraday high of Rs 38.06 today, indicating strong buying interest. Overall, these factors contribute to the current rise in Integrated Proteins Ltd's stock price.

Why is Integrated Proteins Ltd falling/rising?

As of 23-Dec, Integrated Proteins Ltd's stock price has fallen to Rs 36.10, a decrease of 5.0%, following a trend reversal after four days of gains. The stock has significantly underperformed its sector and the broader market, with a year-to-date decline of 51.99%.

As of 23-Dec, Integrated Proteins Ltd's stock price is falling, currently at Rs 36.10, which represents a decrease of Rs 1.9 or 5.0%. This decline follows a trend reversal after four consecutive days of gains. The stock has underperformed its sector by 0.86% today and has shown erratic trading patterns, not trading on one day out of the last twenty. <BR><BR>Additionally, the stock reached an intraday low of Rs 36.1, indicating significant downward pressure. The weighted average price suggests that more volume was traded closer to this low price, further reflecting bearish sentiment. The stock's delivery volume has also seen a drastic decline, with a 92.07% drop compared to the five-day average, indicating falling investor participation. <BR><BR>In the broader context, the stock has underperformed significantly over longer periods, with a year-to-date decline of 51.99% and a one-year decline of 51.07%, while the benchmark Sensex has shown positive returns in those same periods. The sector itself, solvent extraction, has also fallen by 4.15%, contributing to the negative sentiment surrounding Integrated Proteins Ltd. Overall, these factors collectively explain the current decline in the stock's price.

Why is Integrated Proteins Ltd falling/rising?

As of 24-Dec, Integrated Proteins Ltd's stock price is stable at 36.10 but has declined significantly over the year by approximately 52%. Despite a recent short-term rise of 9.73%, investor participation has dropped notably, indicating mixed market sentiment.

As of 24-Dec, Integrated Proteins Ltd's stock price is currently stable at 36.10, showing no change (0.00%). However, the stock has experienced a significant decline over the year, with a year-to-date drop of 51.99% and a one-year decline of 52.03%. Despite this, the stock has shown a positive performance in the last week, rising by 9.73%, which is a notable outperformance compared to the Sensex's increase of only 1.00% during the same period.<BR><BR>Today's trading performance indicates that the stock has outperformed its sector by 1.6%. However, there are signs of erratic trading, as the stock did not trade on one day out of the last 20 days, which may contribute to uncertainty among investors. Additionally, there has been a significant drop in investor participation, with delivery volume on 23 December falling by 55.84% compared to the five-day average. <BR><BR>While the stock is currently trading above its 5-day, 20-day, and 50-day moving averages, it remains below its 100-day and 200-day moving averages, suggesting a mixed outlook. The liquidity of the stock is adequate for trading, but the declining delivery volume indicates a potential lack of confidence among investors. Overall, the stock's recent rise in the short term contrasts sharply with its long-term performance, reflecting a complex situation for Integrated Proteins Ltd.

Why is Integrated Proteins Ltd falling/rising?

As of 25-Dec, Integrated Proteins Ltd's stock price is stable at 36.10 but has declined significantly by 51.99% YTD and 52.03% over the past year. Despite a short-term outperformance relative to its sector, long-term trends and decreased investor participation suggest ongoing challenges for the company.

As of 25-Dec, Integrated Proteins Ltd's stock price is currently stable at 36.10, showing no change (0.00%). However, the stock has experienced a significant decline over the year, with a year-to-date (YTD) decrease of 51.99% and a one-year decline of 52.03%. This long-term downward trend contrasts sharply with the Sensex, which has increased by 9.30% YTD and 8.84% over the past year.<BR><BR>In the short term, the stock has outperformed its sector by 1.6% today, indicating some positive movement relative to its peers. However, the trading activity has been erratic, with the stock not trading on one day out of the last 20 days. Additionally, there has been a notable decrease in investor participation, as evidenced by a 55.84% drop in delivery volume on December 23 compared to the five-day average. <BR><BR>The stock's moving averages reflect a mixed picture; while it is currently higher than the 5-day, 20-day, and 50-day moving averages, it remains lower than the 100-day and 200-day moving averages, suggesting that the stock may be experiencing short-term fluctuations without a strong upward trend. Overall, despite today's relative outperformance, the significant declines over the longer term and falling investor participation indicate that Integrated Proteins Ltd is facing challenges that may contribute to its overall negative performance.

Why is Integrated Proteins Ltd falling/rising?

As of 26-Dec, Integrated Proteins Ltd's stock price is stable at 36.10 but has seen significant declines, including a year-to-date drop of 51.99%. The stock's performance indicates a lack of investor confidence, with reduced delivery volume and underperformance compared to market benchmarks.

As of 26-Dec, Integrated Proteins Ltd's stock price is currently stable at 36.10, showing no change (0.00%). However, the stock has experienced significant declines over various periods, with a year-to-date drop of 51.99% and a one-year decrease of 52.96%. In the past month, the stock has fallen by 5.62%, while the stock's performance over the last week shows a slight decline of 0.41%. <BR><BR>Despite today's performance indicating that the stock has outperformed its sector by 3.91%, the overall trend suggests a lack of investor confidence, as evidenced by a drastic reduction in delivery volume, which has fallen by 87.26% compared to the five-day average. Additionally, while the stock is trading above its 5-day, 20-day, and 50-day moving averages, it remains below the 100-day and 200-day moving averages, indicating potential weakness in the longer-term trend.<BR><BR>The broader market context shows that the Sensex has gained 8.83% year-to-date, contrasting sharply with Integrated Proteins Ltd's performance. The sector, Solvent Extraction, has also declined by 3.91%, which may contribute to the stock's struggles. Overall, the combination of significant declines over various time frames, reduced investor participation, and underperformance relative to the sector and market benchmarks suggests that Integrated Proteins Ltd's stock is currently facing downward pressure.